ZNTL - Zentalis Pharmaceuticals Llc - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ZNTL is currently covered by 11 analysts with an average price target of $9.89. This is a potential upside of $8.63 (684.92%) from yesterday's end of day stock price of $1.26.

Zentalis Pharmaceuticals Llc's activity chart (see below) currently has 60 price targets and 80 ratings on display. The stock rating distribution of ZNTL is 74.42% BUY, 23.26% HOLD and 2.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28.47% with an average time for these price targets to be met of 38.08 days.

Highest price target for ZNTL is $10, Lowest price target is $2.2, average price target is $13.56.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 28-Mar-2025. First documented stock forecast 28-Apr-2020.

Currently out of the existing stock ratings of ZNTL, 32 are a BUY (74.42%), 10 are a HOLD (23.26%), 1 are a SELL (2.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$4

$2.55 (175.86%)

$4

1 months 11 days ago
(28-Mar-2025)

4/10 (40%)

$2.19 (120.99%)

20

Buy

$10

$8.55 (589.66%)

$10

1 months 12 days ago
(27-Mar-2025)

3/15 (20%)

$8.21 (458.66%)

135

Hold

$2.2

$0.75 (51.72%)

$5

3 months 11 days ago
(28-Jan-2025)

3/5 (60%)

$-0.2 (-8.33%)

18

Buy

$8

$6.55 (451.72%)

$28

5 months 24 days ago
(15-Nov-2024)

2/3 (66.67%)

$4.53 (130.55%)

108

Buy

7 months 23 days ago
(16-Sep-2024)

0/5 (0%)

$19.95 (66.39%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ZNTL (Zentalis Pharmaceuticals Llc) average time for price targets to be met?

On average it took 38.08 days on average for the stock forecasts to be realized with a an average price target met ratio 28.47

Which analyst has the current highest performing score on ZNTL (Zentalis Pharmaceuticals Llc) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on ZNTL (Zentalis Pharmaceuticals Llc)?

Andrew Fein has 22 price targets and 23 ratings on ZNTL

Which analyst is the currently most bullish on ZNTL (Zentalis Pharmaceuticals Llc)?

Biren Amin with highest potential upside - $68.55

Which analyst is the currently most reserved on ZNTL (Zentalis Pharmaceuticals Llc)?

Matthew Biegler with lowest potential downside - -$0

Zentalis Pharmaceuticals Llc in the News

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that on May 1, 2025, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?